Origin Energy (ASX: ORG) delivers A$911m APLNG dividend but flags FY27 decline as data breach exposes 900,000 customers
Read More Company Profiles Pharma Industry News Orchid Pharma company profile: business model, financials, and growth outlook (2026 Edition) Orchid Pharma Limited company profile: cephalosporin API leader, FY2025 revenue Rs. 921.93 Cr, Jammu PLI expansion, novel antibiotic pipeline, and 2026-27 growth outlook. bySrinathApril 4, 2026